Results 71 to 80 of about 802,496 (169)
Outcomes after Transcatheter Mitral Valve Implantation: A Literature Review
Mitral valve disease is the most common heart valve disease worldwide. Surgical mitral valve replacement or repair has been an established therapy in patients with severe mitral valve disease for many years. On the other hand, many patients with advanced
Konstantinos Perreas +5 more
core +1 more source
Current Devices in TMVI and Their Limitations: Focus on Tendyne
Mitral valve regurgitation (MR) has a high incidence in the western world, and mortality is high for untreated severe MR. Catheter based repair was introduced with MitraClip in 2003, and some additional devices later came into the market.
Gry Dahle
doaj +1 more source
Patients aged ≥ 80 years with atrial fibrillation underwent catheter ablation. At 2 years, the recurrence‐free survival rate was 85.8% in paroxysmal AF and 63.6% in persistent AF (p = 0.024), and periprocedural complications occurred in 12.0%, including severe complications in 3.3%.
Takumi Tamura +14 more
wiley +1 more source
Prognostic Markers in Transcatheter Mitral Valve Repair [PDF]
The Mitraclip procedure is at present the most widely available method for transcatheter correction of severe mitral regurgitation (MR). The efficacy and the safety of the device has been evaluated in the EVEREST II randomized control study1 (head to ...
Chrissoheris, Michael
core +1 more source
Introduction and objectives: Mitral regurgitation is one society’s most prevalent valvular diseases. Transcatheter mitral valve repair with the MitraClip system has become more widely used for the management of this condition.
Alberto Alperi García +10 more
doaj +1 more source
Current Topics of Progressive Cardiac Conduction Disease
Many genes and the protein cause PCCD. Mutation of NaV1.5 or CX40 cause isolated PCCD, but mutation of lamin A/C, emerin, or desmin lead to cardiomyopathy, and PCCD. Mutation of transcription factor NCX2‐5, and Tbx5 associated with atrial septal defect and abnormal development of conduction system.
Naokata Sumitomo +7 more
wiley +1 more source
Background In symptomatic high-risk patients with severe mitral valve regurgitation (MR), who are not eligible for surgery, Transcatheter edge-to-edge repair (TEER) or transcatheter mitral valve replacement (TMVR) may be an option, especially when ...
A. Maloku +7 more
doaj +1 more source
Cardiovascular Health in Women—Across the Lifespan
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar +5 more
wiley +1 more source
Background: Mitral annular calcification (MAC) complicates transcatheter interventions for degenerative mitral regurgitation (DMR), particularly with small mitral valve orifice areas (MVOAs). Case Summary: An 83-year-old woman with severe DMR, severe MAC,
John Abdelmalek, MD +6 more
doaj +1 more source

